Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.9065
+0.0082 (0.91%)
Feb 25, 2026, 4:00 PM EST - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $118.27 million as of February 25, 2026. Its market cap has increased by 36.66% in one year.
Market Cap
118.27M
Enterprise Value
85.17M
1-Year Change
36.66%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $118.27M, a decrease of -51.45%. That is a compound annual growth rate of -9.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 117.20M | 82.56% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spero Therapeutics | 124.51M |
| Artiva Biotherapeutics | 122.72M |
| Cardiff Oncology | 120.58M |
| Oncolytics Biotech | 118.96M |
| MacroGenics | 118.29M |
| Coya Therapeutics | 117.24M |
| Seer, Inc. | 116.44M |
| Korro Bio | 115.17M |